These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


109 related items for PubMed ID: 3832667

  • 1. Tumor inhibition by ferricenium complexes: systemic effect in vivo and cell growth inhibition in vitro.
    Köpf-Maier P.
    Z Naturforsch C Biosci; 1985; 40(11-12):843-6. PubMed ID: 3832667
    [Abstract] [Full Text] [Related]

  • 2. Ferricenium complexes: a new type of water-soluble antitumor agent.
    Köpf-Maier P, Köpf H, Neuse EW.
    J Cancer Res Clin Oncol; 1984; 108(3):336-40. PubMed ID: 6511806
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Early effects of cis-dichlorodiammine platinum (II) on tumor progression and programmed death of Ehrlich ascites carcinoma cells.
    Razin BV, Inzhevatkin EV, Nefedova VV, Egorova AB, Kazbanov VI, Nefedov VP.
    Bull Exp Biol Med; 2001 Jun; 131(6):568-9. PubMed ID: 11586409
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antitumor effectiveness and mechanism of action of Ru(II)/amino acid/diphosphine complexes in the peritoneal carcinomatosis progression.
    Mello-Andrade F, da Costa WL, Pires WC, Pereira FC, Cardoso CG, Lino-Junior RS, Irusta VRC, Carneiro CC, de Melo-Reis PR, Castro CH, Almeida MAP, Batista AA, Silveira-Lacerda EP.
    Tumour Biol; 2017 Oct; 39(10):1010428317695933. PubMed ID: 29019283
    [Abstract] [Full Text] [Related]

  • 11. Synthesis, structure, electrochemistry and spectral characterization of (D-glucopyranose)-4-phenylthiosemicarbazide metal complexes and their antitumor activity against Ehrlich ascites carcinoma in Swiss albino mice.
    Sathisha MP, Budagumpi S, Kulkarni NV, Kurdekar GS, Revankar VK, Pai KS.
    Eur J Med Chem; 2010 Jan; 45(1):106-13. PubMed ID: 19854545
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of Ehrlich ascites tumor in vivo by PAF-antagonists.
    Fecchio D, Russo M, Sirois P, Braquet P, Jancar S.
    Int J Immunopharmacol; 1990 Jan; 12(1):57-65. PubMed ID: 2303318
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antitumor activity of titanocene amino acid complexes.
    Köpf-Maier P, Tornieporth-Oetting IC.
    Biometals; 1996 Jul; 9(3):267-71. PubMed ID: 8696077
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.